<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-07687</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0004492</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Genetics and Genomics/Disease Models</subject><subject>Genetics and Genomics/Functional Genomics</subject><subject>Genetics and Genomics/Genetics of Disease</subject><subject>Genetics and Genomics/Medical Genetics</subject></subj-group></article-categories><title-group><article-title>Heterozygous Mutation of Opa1 in <italic>Drosophila</italic> Shortens Lifespan Mediated through Increased Reactive Oxygen Species Production</article-title><alt-title alt-title-type="running-head"><italic>dOpa1</italic> Mutation and Lifespan</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Sha</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Le</surname><given-names>Phung Khanh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tse</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wallace</surname><given-names>Douglas C.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Taosheng</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Division of Human Genetics, Department of Pediatrics, University of California Irvine, Irvine, California, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Center for Molecular and Mitochondrial Medicine and Genetics, University of California Irvine, Irvine, California, United States of America</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Department of Biological Chemistry, University of California Irvine, Irvine, California, United States of America</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Department of Developmental and Cell Biology, University of California Irvine, Irvine, California, United States of America</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Department of Pathology, University of California Irvine, Irvine, California, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Nollen</surname><given-names>Ellen A. A.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University Medical Center Groningen, Netherlands</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>huangts@uci.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: ST TH. Performed the experiments: ST PKL ST. Analyzed the data: ST TH. Wrote the paper: ST DW TH.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>16</day><month>2</month><year>2009</year></pub-date><volume>4</volume><issue>2</issue><elocation-id>e4492</elocation-id><history><date date-type="received"><day>10</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>19</day><month>12</month><year>2008</year></date></history><copyright-statement>Tang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><p>Optic atrophy 1 (OPA1) is a dynamin-like GTPase located in the inner mitochondrial membrane and mutations in <italic>OPA1</italic> are associated with autosomal dominant optic atrophy (DOA). OPA1 plays important roles in mitochondrial fusion, cristae remodeling and apoptosis. Our previous study showed that <italic>dOpa</italic>1 mutation caused elevated reactive oxygen species (ROS) production and resulted in damage and death of the cone and pigment cells in <italic>Drosophila</italic> eyes. Since ROS-induced oxidative damage to the cells is one of the primary causes of aging, in this study, we examined the effects of heterozygous <italic>dOpa</italic>1 mutation on the lifespan. We found that heterozygous <italic>dOpa</italic>1 mutation caused shortened lifespan, increased susceptibility to oxidative stress and elevated production of ROS in the whole <italic>Drosophila</italic>. Antioxidant treatment partially restored lifespan in the male <italic>dOpa1</italic> mutants, but had no effects in the females. Heterozygous <italic>dOpa</italic>1 mutation caused an impairment of respiratory chain complex activities, especially complexes II and III, and reversible decreased aconitase activity. Heterozygous <italic>dOpa</italic>1 mutation is also associated with irregular and dysmorphic mitochondria in the muscle. Our results, for the first time, demonstrate the important role of OPA1 in aging and lifespan, which is most likely mediated through augmented ROS production.</p></abstract><counts><page-count count="9"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>OPA1 is a ubiquitously expressed large dynamin-related GTPase, encoded by the nuclear genome and targeted to the inner mitochondrial membrane <xref ref-type="bibr" rid="pone.0004492-Alexander1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004492-Misaka1">&#x0005b;3&#x0005d;</xref>. The predicted structure of OPA1 reveals a mitochondrial targeting signal, a transmembrane domain, a presenilin-associated rhomboid-like protease (PARL) recognition site, and a dynamin/GTPase domain. The mitochondrial inner membrane PARL is required for the correct proteolytical processing of OPA1 and subsequent assembly of OPA1 oligomers <xref ref-type="bibr" rid="pone.0004492-Pellegrini1">&#x0005b;4&#x0005d;</xref>. OPA1 promotes mitochondrial fusion and is essential for maintaining normal mitochondrial morphology. In addition, OPA1 regulates cytochrome c mediated apoptosis by modulating mitochondrial cristae structures <xref ref-type="bibr" rid="pone.0004492-Cipolat1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004492-Frezza1">&#x0005b;6&#x0005d;</xref>.</p><p>In human, mutations of OPA1 cause dominant optic atrophy (DOA), the most common form of autosomal inherited optic neuropathy. DOA is characterized by degeneration of retinal ganglion cells <xref ref-type="bibr" rid="pone.0004492-Kjer1">&#x0005b;7&#x0005d;</xref> and progressive loss of vision <xref ref-type="bibr" rid="pone.0004492-Votruba1">&#x0005b;8&#x0005d;</xref>. Optical atrophy can be accompanied by deafness and/or neurological manifestations <xref ref-type="bibr" rid="pone.0004492-AmatiBonneau1">&#x0005b;9&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004492-Hudson1">&#x0005b;12&#x0005d;</xref>. The most prevalent form of DOA is caused by mutations in the OPA1 protein <xref ref-type="bibr" rid="pone.0004492-Eiberg1">&#x0005b;13&#x0005d;</xref>. Although a substantial progress has been made to unravel the molecular function of OPA1, the pathogenesis of DOA remains poorly understood. Recently, we have generated a <italic>Drosophila</italic> knockout model for optic atrophy <xref ref-type="bibr" rid="pone.0004492-Yarosh1">&#x0005b;14&#x0005d;</xref>. Heterozygous mutation of <italic>dOpa1</italic> by a P-element or transposon insertions caused no discernable eye phenotype under a light microscope, whereas the homozygous mutation resulted in embryonic lethality. In the eye-specific somatic clones, the somatic homozygous mutation of <italic>dOpa1</italic> in the eyes caused rough (mispatterning) and glossy (decreased lens and pigment deposition) eye phenotypes in adult <italic>Drosophila</italic>. In <italic>Drosophila</italic> eyes, <italic>dOpa</italic>1 mutation resulted in elevated ROS generation and mitochondrial fragmentation associated with damage and death of the cone and pigment cells. Treatment with antioxidants or superoxide dismutase (SOD1), as well as over-expression of human SOD1 did reverse the glossy phenotype, further indicating the important role of ROS in etiology of optic atrophy.</p><p>ROS remain as one of the most widely accepted cause of aging. Mitochondrial dysfunction was shown to affect longevity <xref ref-type="bibr" rid="pone.0004492-Pellegrini1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004492-BossyWetzel1">&#x0005b;15&#x0005d;</xref>. Aging in biological systems is also accompanied by mitochondrial morphological changes <xref ref-type="bibr" rid="pone.0004492-BossyWetzel1">&#x0005b;15&#x0005d;</xref>. Reducing mitochondrial fission in two fungi models resulted in decreased mitochondrial fragmentation and extended lifespan by increased resistance to induction of apoptosis <xref ref-type="bibr" rid="pone.0004492-Scheckhuber1">&#x0005b;16&#x0005d;</xref>. Since OPA1 is ubiquitously expressed and <italic>OPA1</italic> mutation is associated with altered mitochondrial dynamics and elevated ROS production in the <italic>Drosophila</italic> retinal cells, OPA1 insufficiency may also accelerate aging and affect lifespan. In this study, we further exploited our <italic>Drosophila</italic> model to investigate the effects of <italic>dOpa</italic>1 mutation on ROS production in <italic>Drosophila</italic>, mitochondrial complex activities and lifespan. We found that heterozygous mutation of <italic>dOpa</italic>1 results in a shortened lifespan, an increased production of ROS, sensitivity to oxidative stress, defects in complex activity of respiratory chain and aberrant mitochondrial morphology. Our studies suggest that heterozygous mutation of <italic>dOpa1</italic> causes shortened lifespan mediated through increased ROS production.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Heterozygous mutation of <italic>dOpa1</italic> results in decreased lifespan in <italic>Drosophila</italic></title><p>To test the hypothesis that heterozygous mutation of <italic>dOpa1</italic> affects the lifespan in <italic>Drosophila</italic>, we performed a longevity assay on a large cohort (n&#x0200a;&#x0003d;&#x0200a;300/genotype) of <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> (<italic>dOpa1<sup>&#x0002b;/in3</sup></italic>, <italic>dOpa1<sup>&#x0002b;/ex2</sup></italic>) and <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic> (<italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic> and <italic>dOpa1<sup>&#x0002b;/ex14</sup></italic>) control <italic>Drosophila</italic>. We previously showed that the P-element insertion in exon 2 (<italic>dOpa1</italic><sup>&#x0002b;/ex2</sup>) and transposon insertion in intron 3 (<italic>dOpa1</italic><sup>&#x0002b;/in3</sup>) disrupted <italic>dOpa1</italic> expression while insertion in non-coding exon 14 had no effect on the dOpa1 protein level, therefore, <italic>dOpa1</italic><sup>&#x0002b;/ex14</sup> also served as a control. <italic>Drosophila</italic> were maintained at 40&#x02013;50 <italic>Drosophila</italic>/vial, transferred to fresh food and counted every 3 days. As shown in <xref ref-type="fig" rid="pone-0004492-g001">Figure 1</xref>, the <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> mutant strain had a significant reduction in both average and maximum lifespan. Since there is no phenotypical difference between <italic>dOpa1<sup>&#x0002b;/in3</sup></italic> and <italic>dOpa1<sup>&#x0002b;/ex2</sup></italic>, <italic>dOpa1<sup>&#x0002b;/in3</sup></italic> is referred as <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> in all subsequent experiments. Wild-type <italic>Drosophila</italic> with the same background are used as the control and referred as <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic>.</p><fig id="pone-0004492-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004492.g001</object-id><label>Figure 1</label><caption><title>Heterozygous <italic>dOpa1</italic> mutations shorten lifespan in <italic>Drosophila</italic>.</title><p>The survival curves for <italic>Drosophila</italic> with P Element insertions in exon2 (<italic>dOpa1<sup>&#x0002b;/ex2</sup></italic>), intron 3 (<italic>dOpa1<sup>&#x0002b;/in3</sup></italic>), and exon 14 (<italic>dOpa1<sup>&#x0002b;/ex14</sup></italic>) of <italic>dOpa1</italic>, as well as wild-type (<italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic>) show that heterozygous mutations in exon 2 and intron 3 of <italic>dOpa1</italic> significantly reduced both median and maximum lifespan. All <italic>dOpa1<sup>&#x0002b;/ex2</sup></italic> and <italic>dOpa1<sup>&#x0002b;/in3</sup> Drosophila</italic> had died by Day 61.</p></caption><graphic xlink:href="pone.0004492.g001"/></fig></sec><sec id="s2b"><title>Heterozygous mutation of <italic>dOpa1</italic> results in decreased resistance to oxidative stress and increased reactive oxygen species (ROS)</title><p>ROS damage biological macromolecules and have been shown to be a major cause of aging. In a previous study, we found that somatically generated homozygous <italic>dOpa</italic>1 mutation large clones displayed higher ROS levels in <italic>dOpa<sup>&#x0002b;/&#x02212;</sup></italic> cells than in <italic>dOpa1<sup>&#x02212;/&#x02212;</sup></italic> cells in the eyes <xref ref-type="bibr" rid="pone.0004492-Yarosh1">&#x0005b;14&#x0005d;</xref>. In this experiment, we used MitoSOX to measured the ROS levels of 7 day old <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> and <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic> whole flies, and observed that both ROS levels and generation rates were significantly elevated in <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup> Drosophila</italic> (<xref ref-type="fig" rid="pone-0004492-g002">Figure 2A, B</xref>).</p><fig id="pone-0004492-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004492.g002</object-id><label>Figure 2</label><caption><title>Heterozygous <italic>dOpa1</italic> mutation results in increased Reactive Oxygen Species (ROS) production and decreased resistance to oxidative stress.</title><p>ROS production rate (A) and ROS levels (B) in <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> and <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup> Drosophila</italic> were measured by MitoSOX fluorescence. Survival curves of <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> and <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup> Drosophila</italic> exposed to 15 mM paraquat (C) indicated that <italic>dOpa1</italic> deficiency was associated with increased sensitivity to paraquat treatment.</p></caption><graphic xlink:href="pone.0004492.g002"/></fig><p>One important genetic determinant for the lifespan of an organism is its sensitivity to oxidative stress <xref ref-type="bibr" rid="pone.0004492-Harman1">&#x0005b;17&#x0005d;</xref>. Paraquat can generate more superoxide anion that can lead to synthesis of more ROS <xref ref-type="bibr" rid="pone.0004492-Suntres1">&#x0005b;18&#x0005d;</xref>. Susceptibility to paraquat can indicate the tolerance of the organism to oxidative stress. To test the overall fitness of <italic>dOpa1</italic><sup>&#x0002b;/&#x02212;</sup> compared to <italic>dOpa</italic>1<sup>&#x0002b;/&#x0002b;</sup><italic>Drosophila</italic>, we exposed adult flies to paraquat for a prolonged period of time and monitored their survival. Compared to control animals, <italic>dOpa1</italic><sup>&#x0002b;/&#x02212;</sup><italic>Drosophila</italic> exhibited a significantly increased sensitivity to oxidative stress (<xref ref-type="fig" rid="pone-0004492-g002">Figure 2C</xref>).</p></sec><sec id="s2c"><title>Heterozygous mutation of <italic>dOpa1</italic> leads to a respiratory defect in Complex II and III of the electron transport chain (ETC)</title><p>In order to further investigate the mechanism by which <italic>dOpa1</italic> mutation elevates ROS, we performed a detailed comparison of respiration of the mitochondria of <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> and <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic> adult <italic>Drosophila</italic> (7 d.o.), as inhibition of the mitochondrial ETC can increase ROS. In oxygen consumption assays, metabolism of NADH-linked complex I substrates pyruvate and malate was unaffected by <italic>dOpa1</italic><sup>&#x0002b;/&#x02212;</sup> mutation while succinate-driven respiration via complex II was significantly decreased (P&#x0003c;0.05) in <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup> Drosophila</italic> (<xref ref-type="fig" rid="pone-0004492-g003">Figure 3A</xref>). Consistent with these findings, while no significant differences were observed in the specific activities of complexes I and IV in 7-day old <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> and <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic> flies, complexes II (38&#x00025; reduction, p&#x0200a;&#x0003d;&#x0200a;0.001) and III (37&#x00025; reduction, p&#x0200a;&#x0003d;&#x0200a;0.026) activities were significantly attenuated in <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup> Drosophila</italic> (<xref ref-type="fig" rid="pone-0004492-g003">Figure 3B</xref>). In 35 d.o. <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies, a similar impairment of enzymatic activities in complexes II (37&#x00025; decrease, p&#x0200a;&#x0003d;&#x0200a;1.97e-07) and III (28&#x00025; decrease, p&#x0200a;&#x0003d;&#x0200a;0.008) was observed. In addition, moderate (10&#x00025;), but significant (p&#x0200a;&#x0003d;&#x0200a;0.02) decline of complex IV activity was observed in 35 d.o. <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies (<xref ref-type="fig" rid="pone-0004492-g003">Figure 3C</xref>). Our result also showed that there was a gender difference in the complex II activity. Heterozygous mutation of <italic>dOpa</italic>1 in males caused more significant inhibition of the complex II activity at 5 week of age (Supplemental <xref ref-type="supplementary-material" rid="pone.0004492.s001">Figure S1</xref>).</p><fig id="pone-0004492-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004492.g003</object-id><label>Figure 3</label><caption><title>Heterozygous <italic>dOpa1</italic> mutation impairs mitochondrial bioenergetics.</title><p>(A) <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup> Drosophila</italic> displayed compromised oxygen consumption driven by complex II substrate succinate. Mitochondrial respiratory chain complexes II and III activities were also significantly attenuated in both 7 d.o. (B) and 35 d.o. (C) <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup> Drosophila</italic>. In the 35-day old <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies, mitochondrial aconitase activities were reduced by 22&#x00025; relative to age-matched controls (D).</p></caption><graphic xlink:href="pone.0004492.g003"/></fig><p>Mitochondria are not only the major sources of ROS production, but the complexes are also vulnerable targets of ROS <xref ref-type="bibr" rid="pone.0004492-Balaban1">&#x0005b;19&#x0005d;</xref>. To investigate whether the decreased complex activities cause increased ROS production or increased ROS inhibits the complex activities in the <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> mutant files, we studied their mitochondrial aconitase activity. In the 7-day old flies, no significant differences in mitochondrial aconitase activities were observed between <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> and <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic> flies (data not shown). However, in the 35-day old <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies, mitochondrial aconitase activities were reduced by 22&#x00025; relative to age-matched controls (<xref ref-type="fig" rid="pone-0004492-g003">Figure 3D</xref>). Furthermore, after reactivation with dithiothreitol and iron, aconitase activity was restored to an even higher level in <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies. This result suggests that ETC dysfunction is the primary cause. Since the inhibition of aconitase activity is only observed in the older flies and the inhibition was reversible, increased ROS may enforce a vicious cycle and further lead to mitochondrial dysfunction.</p></sec><sec id="s2d"><title>The shortened lifespan of heterozygous <italic>dOpa1</italic> mutants is extendable through the administration of antioxidants in male flies, but not in female flies</title><p>Exogenously supplemented antioxidant can detoxify ROS and may retard aging. We have shown that antioxidant treatments were able to ameliorate ROS damage-induced glossy eye phenotype in <italic>dOpa</italic>1 mutant large clones <xref ref-type="bibr" rid="pone.0004492-Yarosh1">&#x0005b;14&#x0005d;</xref>. To study if antioxidant administration can reverse the observed reduced lifespan of the <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> mutant strain, we added MnTBAP to the fly food and generated the survival curves for <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies. Since males and females of the same species may differ in their responses to interventions that affect lifespan <xref ref-type="bibr" rid="pone.0004492-Ballard1">&#x0005b;20&#x0005d;</xref>, we separated male and female flies in the survival study. Indeed we observed sex-specific effects of antioxidant on lifespan in <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies. While MnTBAP treatment showed no consequences on lifespan of female <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies, significantly increased lifespan (50&#x00025; survival time increased by 7 days) was observed in antioxidant-fed male <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies (<xref ref-type="fig" rid="pone-0004492-g004">Figure 4</xref>).</p><fig id="pone-0004492-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004492.g004</object-id><label>Figure 4</label><caption><title>The shortened lifespan of heterozygous <italic>dOpa1</italic> mutants is extendable through the administration of antioxidants in male flies, but not in female flies.</title><p><italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> mutants and <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic> controls were transferred to fresh food every two to three days while aging. Male and female <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup> Drosophila</italic> and <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup>Drosophila</italic> were separated and maintained on with and without 100 &#x000b5;M MnTBAP antioxidant food. Longevity assays were performed. MnTBAP feeding significantly extended lifespan of male <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup> Drosophila</italic> (A), but not in the females (B).</p></caption><graphic xlink:href="pone.0004492.g004"/></fig></sec><sec id="s2e"><title>Heterozygous mutation of <italic>dOpa1</italic> results in highly irregular and dysmorphic mitochondria in the skeletal muscle of adult <italic>Drosophila</italic></title><p>We previously described morphologically perturbed mitochondria in <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> cells of &#x02018;large clone&#x02019; <italic>Drosophila</italic> compound eyes <xref ref-type="bibr" rid="pone.0004492-Yarosh1">&#x0005b;14&#x0005d;</xref>. Since OPA1 is ubiquitously expressed, it is interesting to investigate if <italic>dOpa1</italic> mutation also leads to morphological aberrancy of mitochondria in other organs than the eyes. We used TEM analysis (<xref ref-type="fig" rid="pone-0004492-g005">Figure 5</xref>) and found that the <italic>dOpa1</italic><sup>&#x0002b;/&#x02212;</sup> mitochondria were highly irregular and dysmorphic (Left) compared to <italic>dOpa1</italic><sup>&#x0002b;/&#x0002b;</sup> mitochondria (Right) in the muscle. This result suggests that heterozygous mutation of <italic>dOpa1</italic> also affects the mitochondrial dynamics in <italic>Drosophila</italic>.</p><fig id="pone-0004492-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004492.g005</object-id><label>Figure 5</label><caption><title><italic>dOpa1</italic><sup>&#x0002b;/&#x02212;</sup> mitochondria are highly irregular and dysmorphic in the muscle.</title><p>Tissues from adult <italic>Drosophila</italic> were analyzed by transmission electron microscopy. Mitochondrial phenotypes in muscle (A, B). The <italic>dOpa1</italic><sup>&#x0002b;/&#x02212;</sup> mitochondria were highly irregular and dysmorphic (Left) compared to wild type mitochondria (Right). Bar&#x0200a;&#x0003d;&#x0200a;0.5 &#x000b5;m.</p></caption><graphic xlink:href="pone.0004492.g005"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>OPA1 is involved in mitochondrial fusion, cristae organization, control of apoptosis, ROS production and mutations in <italic>OPA1</italic> genes lead to DOA. Using the <italic>Drosophila</italic> model, we demonstrated that heterozygous mutation of <italic>dOpa1</italic> resulted in a shortened lifespan, enhanced production of ROS and boosted sensitivity to oxidative stress. Impairment of respiratory chain complex activities and age-dependent defects in aconitase activity were also observed, which is associated with irregular and dysmorphic mitochondria in the skeletal muscle. In male <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies, shortened lifespan can be increased by administration of antioxidants.</p><p>Mitochondrial energy metabolism and ROS toxicity are important factors affecting <italic>Drosophila</italic> aging. The <italic>Indy</italic> mutant restricting the availability of calories lived longer <xref ref-type="bibr" rid="pone.0004492-Rogina1">&#x0005b;21&#x0005d;</xref>. Transgenic flies expressing increased Cu/ZnSOD and catalase <xref ref-type="bibr" rid="pone.0004492-Orr1">&#x0005b;22&#x0005d;</xref> displayed extended lifespan. OPA1 is an important regulator of mitochondrial fusion and provide protection for the mitochondria from damage. OPA1 mutations in DOA patients have been associated with mitochondrial fragmentation <xref ref-type="bibr" rid="pone.0004492-Davies1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004492-Olichon1">&#x0005b;24&#x0005d;</xref>, mtDNA copy number reduction <xref ref-type="bibr" rid="pone.0004492-Kim1">&#x0005b;25&#x0005d;</xref> and deletions <xref ref-type="bibr" rid="pone.0004492-Hudson1">&#x0005b;12&#x0005d;</xref>, reduced ATP generation capability <xref ref-type="bibr" rid="pone.0004492-Lodi1">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004492-Zanna1">&#x0005b;27&#x0005d;</xref>, and increased susceptibility to apoptosis <xref ref-type="bibr" rid="pone.0004492-Olichon2">&#x0005b;28&#x0005d;</xref>. All these suggest OPA1 insufficiency relates to mitochondrial dysfunction, a well-known factor contributing to accelerated senescence, implicating the involvement of OPA1 in aging. Indeed, in our <italic>Drosophila</italic> model, lifespan of the <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> mutants was significantly reduced, demonstrating the important role of OPA1 in longevity. We also observed increased mitochondrial ROS levels and production rates in <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> adult <italic>Drosophila</italic>. Excessive mitochondrial ROS can shorten the lifespan by directly impairing mitochondrial genome, lipids of the inner membrane, mitochondrial protein activity and/or affecting nuclear gene transcription.</p><p>In our <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup> Drosophila</italic> model, the most severely damaged electron transport chain unit is complex II, suggesting that complex II is an important determinant of <italic>Drosophila</italic> lifespan. This result is consistent with a comprehensive study of the lifespan in <italic>Drosophila</italic> with RNAi-inactivation of nuclear genome-encoded mitochondrial complexes I&#x02013;V genes. The study shows one third of the RNAi lines that exhibited altered lifespan resulted from inactivation of complex II-encoding genes (David Walker, UCLA, personal communication).</p><p>In Hela cells, inhibition of Drp1 modifies the pattern of OPA1 isoforms, results in dysfunction of OPA1 and leads to a significant decrease in complex II respiration with complex I function intact <xref ref-type="bibr" rid="pone.0004492-Estaquier1">&#x0005b;29&#x0005d;</xref>. The correlation between OPA1 defect and complex II dysfunction in both flies and Hela cells suggests that the mitochondria structure is important for integrity of complex II functions.</p><p>Mitochondrial complex II oxidizes succinate to fumarate and passes the electrons into the quinine, thus serving as the only mitochondrial membrane complex involved in both electron transport and the tricarboxylic acid cycle. It was shown that complex II defect alone is associated with an increased level of ROS <xref ref-type="bibr" rid="pone.0004492-Walker1">&#x0005b;30&#x0005d;</xref>. Mutation in <italic>sdhB</italic> in <italic>Drosophila</italic>, encoding for subunit B of complex II, displays structural abnormalities in the mitochondria, causes an increased level of mitochondrial hydrogen peroxide, and is associated with hypersensitive to oxygen and shortened lifespan <xref ref-type="bibr" rid="pone.0004492-Walker1">&#x0005b;30&#x0005d;</xref>. In <italic>Caenorhabditis elegans</italic>, a mutation in mev-1, encoding for a subunit of complex II, also resulted in augmented ROS production and shortened lifespan <xref ref-type="bibr" rid="pone.0004492-Ishii1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004492-SenooMatsuda1">&#x0005b;32&#x0005d;</xref>. In fact, the short-lived mutant exhibited increased level of nuclear damage, demonstrating mitochondrial derived oxidants may also be a significant source of overall genomic instability <xref ref-type="bibr" rid="pone.0004492-Hartman1">&#x0005b;33&#x0005d;</xref>. Whether OPA1 deficiency leads to nuclear complex II gene transcriptional reduction, damage to complex assembly or protein function remains to be elucidated.</p><p>In contrast to our data, in OPA-RNAi MEF cells, knock down of OPA1 induced a severe reduction in respiration, and oxygen consumption for complexes I, III and IV were all compromised <xref ref-type="bibr" rid="pone.0004492-Chen2">&#x0005b;34&#x0005d;</xref>. Fibroblast cells derived from DOA patients with missense mutation showed a significant impairment of oxidative phosphorylation (OXPHOS), mostly mediated by complex I <xref ref-type="bibr" rid="pone.0004492-Zanna1">&#x0005b;27&#x0005d;</xref>. Furthermore, Co-immunoprecipitation experiments revealed a direct interaction between OPA1 and complexes I, II, and III, but not IV <xref ref-type="bibr" rid="pone.0004492-Zanna1">&#x0005b;27&#x0005d;</xref>. The discrepancy might be associated with the type of cells investigated &#x02014; cultured fibroblast cells preferentially use anaerobic glycolysis for energy production and so mitochondrial OXPHOS in MEF might be metabolically different from that <italic>in vivo</italic>. In addition, different <italic>OPA1</italic> mutations can also result in variable energy defects <xref ref-type="bibr" rid="pone.0004492-Spinazzi1">&#x0005b;35&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004492-Mayorov1">&#x0005b;36&#x0005d;</xref>. In our experiments, mutant <italic>dOpa</italic>1 <italic>Drosophila</italic> were generated by P-element or transposon insertion and resulted in <italic>dOpa</italic>1 haploinsufficiency.</p><p>ROS can damage the electron transport chain. The respiratory chain malfunction can also lead to increased ROS production, constituting a reinforcing vicious cycle and possibly resulting in catastrophic breakdown of mitochondrial function <xref ref-type="bibr" rid="pone.0004492-Chan1">&#x0005b;37&#x0005d;</xref>. In the <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies, both increased ROS levels and compromised ETC functions were observed. It is intriguing to investigate which serves as the primary cause. To distinguish between these two possibilities, we studied mitochondrial aconitase activity. At one week of age, heterozygous mutation of <italic>dOpa</italic>1 caused a significant decrease in the complex activities, but aconitase activity was normal, suggesting that dysfunction of ETC is the primary cause. However, we also observed an age-dependent aconitase activity decline and an elevated aconitase protein level in <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies after reactivation at 5 weeks of age, suggesting that the aconitase activity reduction was the consequence of inactivation of existing enzyme by increased ROS. The elevated amount of extant aconitase in <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> flies might reflect the physiological responses to synthesize more aconitase protein to compensate for the reduction in enzymatic activities. These data indicate that decreased complex activities are the primary underlying mechanism and the secondary increase of ROS reinforces vicious cycle and results in catastrophic mitochondrial dysfunction, including decrease in ATP production. The gradual accumulation of ROS and resultant chronic damage to the mitochondria is consistent with the progressive manifestation of phenotypes in OPA1-related DOA patients.</p><p>Gender is an important and profound factor in aging and lifespan and it is predicted that the longer-lived gender should have lower levels of oxidative stress. In both mammals and flies, females generally have a longer lifespan, possibly due to the sub-optimal mitochondrial function in the males <xref ref-type="bibr" rid="pone.0004492-Tower1">&#x0005b;40&#x0005d;</xref>. The insulin/IGF pathway <xref ref-type="bibr" rid="pone.0004492-Balaban1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004492-Clancy1">&#x0005b;41&#x0005d;</xref> and JNK-dependent signaling <xref ref-type="bibr" rid="pone.0004492-Wang1">&#x0005b;42&#x0005d;</xref> are important regulators for tolerance to oxidative stress and longevity in <italic>Drosophila</italic> and both cascades can be activated by ROS. Generally, females respond better to antioxidant interventions. The lifespan extension impacts of human SOD over-expression in <italic>Drosophila</italic> were more obvious in the females in six out of ten different genetic backgrounds studied while only one male background showed significant increase <xref ref-type="bibr" rid="pone.0004492-Spencer1">&#x0005b;43&#x0005d;</xref>. Interestingly, the antioxidant rescue of lifespan for heterozygous <italic>dOpa</italic>1 mutants is only effective in the males, but not in the females in our study, which is consistent with the complex II activity. The gender-specific variation of antioxidant influence can also be explained by differences in feeding habits and/or distinct responses to intracellular redox status changes between male and female flies.</p><p>In summary, OPA1 deficiency causes malfunction of ETC and results in elevated production of ROS, which in turn can further impaired the complex activity and mitochondrial bioenergetic capability and consequently accelerate aging in <italic>dOpa</italic>1<sup>&#x0002b;/&#x02212;</sup> mutants. Whether OPA1 insufficiency causes ETC dysfunction and induces augmented ROS generation is independent of its role in mitochondrial dynamics and apoptosis, as suggested in the <italic>C. elegans</italic> DOA model <xref ref-type="bibr" rid="pone.0004492-Kanazawa1">&#x0005b;44&#x0005d;</xref>, requires furthering elucidation. In the future, the observations from the <italic>Drosophila</italic> DOA model can be extended to human DOA subjects and have the potential to establish a new model for longevity. Data presented in this study also suggest that antioxidants can sequester ROS and may hold potential as an effective therapeutic agent in this condition.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title><italic>Drosophila</italic> stocks</title><p>y&#x0005b;d2&#x0005d; w&#x0005b;1118&#x0005d; P{ry&#x0005b;&#x0002b;t7.2&#x0005d;&#x0200a;&#x0003d;&#x0200a;<italic>ey</italic>-FLP.N}2; P{ry&#x0005b;&#x0002b;t7.2&#x0005d;&#x0200a;&#x0003d;&#x0200a;neoFRT}42D PBac{WH}CG8479<sup>f02779</sup> (<italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic>) and y&#x0005b;d2&#x0005d; w&#x0005b;1118&#x0005d; P{ry&#x0005b;&#x0002b;t7.2&#x0005d;&#x0200a;&#x0003d;&#x0200a;<italic>ey</italic>-FLP.N}2; P{ry&#x0005b;&#x0002b;t7.2&#x0005d;&#x0200a;&#x0003d;&#x0200a;neoFRT}42D PBac{WH}CG8479<sup>f03594</sup> (<italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic>) <italic>Drosophila</italic> were used in this study. These stocks were established in a previous study <xref ref-type="bibr" rid="pone.0004492-Yarosh1">&#x0005b;14&#x0005d;</xref>. <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic> mutant type and <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic> control were transferred to new food every two to three days while aging. <italic>dOpa1<sup>&#x0002b;/&#x02212;</sup></italic><sup>(antiox)</sup><italic>Drosophila</italic> and <italic>dOpa1<sup>&#x0002b;/&#x0002b;</sup></italic><sup>(antiox)</sup><italic>Drosophila</italic> are heterozygous mutant or wild-type <italic>Drosophila</italic> and were kept on antioxidant food.</p></sec><sec id="s4b"><title>Longevity assay and <italic>Drosophila</italic> husbandry</title><p>Lifespan was determined under standard conditions for <italic>Drosophila</italic> husbandry (25&#x000b0;C, 50&#x00025; Humidity, 12 hour light cycle) as described before <xref ref-type="bibr" rid="pone.0004492-Tong1">&#x0005b;46&#x0005d;</xref>. <italic>Drosophila</italic> were collected over a 24 hour period and aged in vials containing standard <italic>Drosophila</italic> media (40&#x02013;50 <italic>Drosophila</italic>/vial; same sex) and transferred every 3&#x02013;6 days to fresh <italic>Drosophila</italic> media.</p></sec><sec id="s4c"><title>ROS measurements</title><p>Adult <italic>Drosophila</italic> were collected within 12 h of emergence under light CO2 anesthesia, and transferred into vials with food in groups of 15, sexes separate. <italic>Drosophila</italic> were tested for the rate of superoxide anion production as well as levels of superoxide using MitoSOX (Invitrogen) based on previously established methods <xref ref-type="bibr" rid="pone.0004492-Yarosh1">&#x0005b;14&#x0005d;</xref>. Briefly, tissue homogenates of 40 adult <italic>Drosophila</italic> were stained with MitoSOX (2.5 mM), and fluorescence was performed at 510 nm exciation/580 nm emission via a Perkin Elmer L20B luminescence spectrometer.</p></sec><sec id="s4d"><title>Paraquat survival</title><p>Adult <italic>Drosophila</italic> were collected within 12 h of emergence under light CO<sub>2</sub> anesthesia, and transferred into vials with food in groups of 15 <italic>Drosophila</italic> per vial, sexes separate. Seven days after emergence, <italic>Drosophila</italic> were tested for resistance to paraquat (Sigma), based on previously established methods <xref ref-type="bibr" rid="pone.0004492-Tong1">&#x0005b;46&#x0005d;</xref>. <italic>Drosophila</italic> were starved for 2 h by placing them in empty vials, and then transferred into test vials containing filter paper disks soaked with 20 mM paraquat and 5&#x00025; sucrose or 5&#x00025; sucrose alone as a control. The starvation treatment ensures that initial ingestion of paraquat does not vary between lines because of differences in feeding status. Numbers of living <italic>Drosophila</italic> were recorded at 24 h intervals.</p></sec><sec id="s4e"><title>Mitochondria isolation and respiration</title><p>Mitochondria were isolated as described before <xref ref-type="bibr" rid="pone.0004492-Tong1">&#x0005b;46&#x0005d;</xref>. Respiration rates were determined by oxygen consumption using a Clark-type electrode and metabolic chamber containing 650 &#x000b5;L of reaction buffer consisting of 225 mM mannitol, 75 mM sucrose, 10 mM KCl, 10 mM Tris-HCl and 5 mM KH<sub>2</sub>PO<sub>4</sub> (pH 7.2) at 25&#x000b0;C. Mitochondrial ATP production rates were calculated from ADP consumption rates during state III respiration.</p></sec><sec id="s4f"><title>Mitochondrial enzyme assays</title><p>Citrate synthase activity was analyzed by the reduction of 5,5&#x02032;-dithiobis-2-nitrobenzoic acid at 412 nm in the presence of acetyl-CoA and oxaloacetate <xref ref-type="bibr" rid="pone.0004492-Barrientos1">&#x0005b;47&#x0005d;</xref>. Aconitase activity was measured by monitoring conversion of citrate into &#x003b1;-ketoglutarate at 340 nm at 25&#x000b0;C using the coupled reduction of NADP to NADPH <xref ref-type="bibr" rid="pone.0004492-Hausladen1">&#x0005b;48&#x0005d;</xref>. Aconitase was reactivated by incubation with 2 mM dithiothreitol and 0.2 mM ferrous ammonium sulfate before repeating the enzymatic activity assays.</p></sec><sec id="s4g"><title>Mitochondrial respiratory chain complex I&#x02013;IV activity assay</title><p>Complex I (NADH dehydrogenase) activity was determined as the rotenone-sensitive NADH oxidation at 340 nm, using the coenzyme Q analogue 2, 3-dimethyl-5-methyl 6-n-decyl-1, 4-benzomethyluinone (DB) as an electron acceptor <xref ref-type="bibr" rid="pone.0004492-Barrientos1">&#x0005b;47&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004492-Trounce1">&#x0005b;49&#x0005d;</xref>. The activity of complex II (succinate dehydrogenase) was analyzed by tracking the secondary reduction of 2,6 &#x02013;dichlorophenolindophenol by ubiquinone-2 at 600 nm <xref ref-type="bibr" rid="pone.0004492-Barrientos1">&#x0005b;47&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004492-Trounce1">&#x0005b;49&#x0005d;</xref>. Complex III (cytochrome <italic>bc<sub>1</sub></italic> complex) activity was determined by measuring the reduction of cytochrome c at 550 nm with reduced decylubiquinone <xref ref-type="bibr" rid="pone.0004492-Barrientos1">&#x0005b;47&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004492-Trounce1">&#x0005b;49&#x0005d;</xref>. Complex IV (cytochrome c oxidase) activity was measured by monitoring the oxidation of reduced cytochrome c as a decrease of absorbance at 550 nm <xref ref-type="bibr" rid="pone.0004492-Barrientos1">&#x0005b;47&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004492-Trounce1">&#x0005b;49&#x0005d;</xref>. Complex I&#x02013;IV activities were normalized by citrate synthase activity and then used in the analysis.</p></sec><sec id="s4h"><title>Transmission electron microscopy (TEM)</title><p>TEM was performed as previously described <xref ref-type="bibr" rid="pone.0004492-Yarosh1">&#x0005b;14&#x0005d;</xref>. Briefly, adult <italic>Drosophila</italic> were fixed overnight in 4&#x00025; paraformaldehyde at 4&#x000b0;C and transferred to a post-fixation solution of 1&#x00025; glutaraldehyde for 1 hour, then rinsed in PBS and placed in 1&#x00025; osmium tetroxide for 20&#x02013;60 min. The samples were dehydrated by ethanol and propylene oxide immersion. A flat-embedding procedure was used followed by trimming of the tissue block with a single-edged razor blade under a dissecting microscope (Nikon). A short series of ultrathin (60&#x02013;80 nm) sections of the whole flies was cut from each block with an ultramicrotome (Reichert-Jung) and serial sections were collected on mesh and formvar-coated slot grids. The sections were stained with uranylacetate and lead citrate to enhance contrast. Skeletal muscle was examined with a Philips CM-10 transmission electron microscope and images of ommatidial units were captured with a Gatan digital camera.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0004492.s001"><label>Figure S1</label><caption><p>Heterozygous dOpa1 mutation causes an age-dependent gender-specific difference of complex II activity decline.</p><p>(0.08 MB JPG)</p></caption><media xlink:href="pone.0004492.s001.jpg" mimetype="image" mime-subtype="jpeg"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We are very grateful to Dr. Zhiyin Shan of Dr. Ribak's Lab, University of California, Irvine for the TEM analysis. We would like to thank Dr. Arnold Starr at University of California, Irvine for his inspiration and stimulating discussions.</p></ack><ref-list><title>References</title><ref id="pone.0004492-Alexander1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>C</given-names></name><name><surname>Votruba</surname><given-names>M</given-names></name><name><surname>Pesch</surname><given-names>UE</given-names></name><name><surname>Thiselton</surname><given-names>DL</given-names></name><name><surname>Mayer</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28.</article-title><source>Nat Genet</source><volume>26</volume><fpage>211</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">11017080</pub-id></citation></ref><ref id="pone.0004492-Delettre1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delettre</surname><given-names>C</given-names></name><name><surname>Lenaers</surname><given-names>G</given-names></name><name><surname>Griffoin</surname><given-names>JM</given-names></name><name><surname>Gigarel</surname><given-names>N</given-names></name><name><surname>Lorenzo</surname><given-names>C</given-names></name><etal/></person-group><year>2000</year><article-title>Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.</article-title><source>Nat Genet</source><volume>26</volume><fpage>207</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">11017079</pub-id></citation></ref><ref id="pone.0004492-Misaka1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Misaka</surname><given-names>T</given-names></name><name><surname>Miyashita</surname><given-names>T</given-names></name><name><surname>Kubo</surname><given-names>Y</given-names></name></person-group><year>2002</year><article-title>Primary structure of a dynamin-related mouse mitochondrial GTPase and its distribution in brain, subcellular localization, and effect on mitochondrial morphology.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>15834</fpage><lpage>15842</lpage><pub-id pub-id-type="pmid">11847212</pub-id></citation></ref><ref id="pone.0004492-Pellegrini1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pellegrini</surname><given-names>L</given-names></name><name><surname>Scorrano</surname><given-names>L</given-names></name></person-group><year>2007</year><article-title>A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis.</article-title><source>Cell Death Differ</source><volume>14</volume><fpage>1275</fpage><lpage>1284</lpage><pub-id pub-id-type="pmid">17464328</pub-id></citation></ref><ref id="pone.0004492-Cipolat1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cipolat</surname><given-names>S</given-names></name><name><surname>Rudka</surname><given-names>T</given-names></name><name><surname>Hartmann</surname><given-names>D</given-names></name><name><surname>Costa</surname><given-names>V</given-names></name><name><surname>Serneels</surname><given-names>L</given-names></name><etal/></person-group><year>2006</year><article-title>Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling.</article-title><source>Cell</source><volume>126</volume><fpage>163</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">16839884</pub-id></citation></ref><ref id="pone.0004492-Frezza1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frezza</surname><given-names>C</given-names></name><name><surname>Cipolat</surname><given-names>S</given-names></name><name><surname>Martins de Brito</surname><given-names>O</given-names></name><name><surname>Micaroni</surname><given-names>M</given-names></name><name><surname>Beznoussenko</surname><given-names>GV</given-names></name><etal/></person-group><year>2006</year><article-title>OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion.</article-title><source>Cell</source><volume>126</volume><fpage>177</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">16839885</pub-id></citation></ref><ref id="pone.0004492-Kjer1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kjer</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>OA</given-names></name><name><surname>Klinken</surname><given-names>L</given-names></name></person-group><year>1983</year><article-title>Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy.</article-title><source>Acta Ophthalmol (Copenh)</source><volume>61</volume><fpage>300</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">6880639</pub-id></citation></ref><ref id="pone.0004492-Votruba1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Votruba</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>AT</given-names></name><name><surname>Bhattacharya</surname><given-names>SS</given-names></name></person-group><year>1998</year><article-title>Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy.</article-title><source>J Med Genet</source><volume>35</volume><fpage>793</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">9783700</pub-id></citation></ref><ref id="pone.0004492-AmatiBonneau1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amati-Bonneau</surname><given-names>P</given-names></name><name><surname>Guichet</surname><given-names>A</given-names></name><name><surname>Olichon</surname><given-names>A</given-names></name><name><surname>Chevrollier</surname><given-names>A</given-names></name><name><surname>Viala</surname><given-names>F</given-names></name><etal/></person-group><year>2005</year><article-title>OPA1 R445H mutation in optic atrophy associated with sensorineural deafness.</article-title><source>Ann Neurol</source><volume>58</volume><fpage>958</fpage><lpage>963</lpage><pub-id pub-id-type="pmid">16240368</pub-id></citation></ref><ref id="pone.0004492-AmatiBonneau2"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amati-Bonneau</surname><given-names>P</given-names></name><name><surname>Valentino</surname><given-names>ML</given-names></name><name><surname>Reynier</surname><given-names>P</given-names></name><name><surname>Gallardo</surname><given-names>ME</given-names></name><name><surname>Bornstein</surname><given-names>B</given-names></name><etal/></person-group><year>2008</year><article-title>OPA1 mutations induce mitochondrial DNA instability and optic atrophy &#x02018;plus&#x02019; phenotypes.</article-title><source>Brain</source><volume>131</volume><fpage>338</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">18158317</pub-id></citation></ref><ref id="pone.0004492-Chen1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>A novel OPA1 mutation responsible for autosomal dominant optic atrophy with high frequency hearing loss in a Chinese family.</article-title><source>Am J Ophthalmol</source><volume>143</volume><fpage>186</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">17188070</pub-id></citation></ref><ref id="pone.0004492-Hudson1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>G</given-names></name><name><surname>Amati-Bonneau</surname><given-names>P</given-names></name><name><surname>Blakely</surname><given-names>EL</given-names></name><name><surname>Stewart</surname><given-names>JD</given-names></name><name><surname>He</surname><given-names>L</given-names></name><etal/></person-group><year>2008</year><article-title>Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance.</article-title><source>Brain</source><volume>131</volume><fpage>329</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">18065439</pub-id></citation></ref><ref id="pone.0004492-Eiberg1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eiberg</surname><given-names>H</given-names></name><name><surname>Kjer</surname><given-names>B</given-names></name><name><surname>Kjer</surname><given-names>P</given-names></name><name><surname>Rosenberg</surname><given-names>T</given-names></name></person-group><year>1994</year><article-title>Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. Linkage analysis.</article-title><source>Hum Mol Genet</source><volume>3</volume><fpage>977</fpage><lpage>980</lpage><pub-id pub-id-type="pmid">7951248</pub-id></citation></ref><ref id="pone.0004492-Yarosh1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yarosh</surname><given-names>W</given-names></name><name><surname>Monserrate</surname><given-names>J</given-names></name><name><surname>Tong</surname><given-names>JJ</given-names></name><name><surname>Tse</surname><given-names>S</given-names></name><name><surname>Le</surname><given-names>PK</given-names></name><etal/></person-group><year>2008</year><article-title>The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment.</article-title><source>PLoS Genet</source><volume>4</volume><fpage>e6</fpage><pub-id pub-id-type="pmid">18193945</pub-id></citation></ref><ref id="pone.0004492-BossyWetzel1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bossy-Wetzel</surname><given-names>E</given-names></name><name><surname>Barsoum</surname><given-names>MJ</given-names></name><name><surname>Godzik</surname><given-names>A</given-names></name><name><surname>Schwarzenbacher</surname><given-names>R</given-names></name><name><surname>Lipton</surname><given-names>SA</given-names></name></person-group><year>2003</year><article-title>Mitochondrial fission in apoptosis, neurodegeneration and aging.</article-title><source>Curr Opin Cell Biol</source><volume>15</volume><fpage>706</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">14644195</pub-id></citation></ref><ref id="pone.0004492-Scheckhuber1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scheckhuber</surname><given-names>CQ</given-names></name><name><surname>Erjavec</surname><given-names>N</given-names></name><name><surname>Tinazli</surname><given-names>A</given-names></name><name><surname>Hamann</surname><given-names>A</given-names></name><name><surname>Nystrom</surname><given-names>T</given-names></name><etal/></person-group><year>2007</year><article-title>Reducing mitochondrial fission results in increased life span and fitness of two fungal ageing models.</article-title><source>Nat Cell Biol</source><volume>9</volume><fpage>99</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">17173038</pub-id></citation></ref><ref id="pone.0004492-Harman1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harman</surname><given-names>D</given-names></name></person-group><year>1956</year><article-title>Aging: a theory based on free radical and radiation chemistry.</article-title><source>J Gerontol</source><volume>11</volume><fpage>298</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">13332224</pub-id></citation></ref><ref id="pone.0004492-Suntres1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suntres</surname><given-names>ZE</given-names></name></person-group><year>2002</year><article-title>Role of antioxidants in paraquat toxicity.</article-title><source>Toxicology</source><volume>180</volume><fpage>65</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">12324200</pub-id></citation></ref><ref id="pone.0004492-Balaban1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname><given-names>RS</given-names></name><name><surname>Nemoto</surname><given-names>S</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name></person-group><year>2005</year><article-title>Mitochondria, oxidants, and aging.</article-title><source>Cell</source><volume>120</volume><fpage>483</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">15734681</pub-id></citation></ref><ref id="pone.0004492-Ballard1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballard</surname><given-names>JW</given-names></name><name><surname>Melvin</surname><given-names>RG</given-names></name><name><surname>Miller</surname><given-names>JT</given-names></name><name><surname>Katewa</surname><given-names>SD</given-names></name></person-group><year>2007</year><article-title>Sex differences in survival and mitochondrial bioenergetics during aging in Drosophila.</article-title><source>Aging Cell</source><volume>6</volume><fpage>699</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">17725690</pub-id></citation></ref><ref id="pone.0004492-Rogina1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rogina</surname><given-names>B</given-names></name><name><surname>Reenan</surname><given-names>RA</given-names></name><name><surname>Nilsen</surname><given-names>SP</given-names></name><name><surname>Helfand</surname><given-names>SL</given-names></name></person-group><year>2000</year><article-title>Extended life-span conferred by cotransporter gene mutations in Drosophila.</article-title><source>Science</source><volume>290</volume><fpage>2137</fpage><lpage>2140</lpage><pub-id pub-id-type="pmid">11118146</pub-id></citation></ref><ref id="pone.0004492-Orr1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orr</surname><given-names>WC</given-names></name><name><surname>Sohal</surname><given-names>RS</given-names></name></person-group><year>1994</year><article-title>Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster.</article-title><source>Science</source><volume>263</volume><fpage>1128</fpage><lpage>1130</lpage><pub-id pub-id-type="pmid">8108730</pub-id></citation></ref><ref id="pone.0004492-Davies1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>VJ</given-names></name><name><surname>Hollins</surname><given-names>AJ</given-names></name><name><surname>Piechota</surname><given-names>MJ</given-names></name><name><surname>Yip</surname><given-names>W</given-names></name><name><surname>Davies</surname><given-names>JR</given-names></name><etal/></person-group><year>2007</year><article-title>Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function.</article-title><source>Hum Mol Genet</source><volume>16</volume><fpage>1307</fpage><lpage>1318</lpage><pub-id pub-id-type="pmid">17428816</pub-id></citation></ref><ref id="pone.0004492-Olichon1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olichon</surname><given-names>A</given-names></name><name><surname>Landes</surname><given-names>T</given-names></name><name><surname>Arnaune-Pelloquin</surname><given-names>L</given-names></name><name><surname>Emorine</surname><given-names>LJ</given-names></name><name><surname>Mils</surname><given-names>V</given-names></name><etal/></person-group><year>2007</year><article-title>Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis.</article-title><source>J Cell Physiol</source><volume>211</volume><fpage>423</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">17167772</pub-id></citation></ref><ref id="pone.0004492-Kim1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Hwang</surname><given-names>JM</given-names></name><name><surname>Ko</surname><given-names>HS</given-names></name><name><surname>Seong</surname><given-names>MW</given-names></name><name><surname>Park</surname><given-names>BJ</given-names></name><etal/></person-group><year>2005</year><article-title>Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.</article-title><source>Neurology</source><volume>64</volume><fpage>966</fpage><lpage>972</lpage><pub-id pub-id-type="pmid">15781809</pub-id></citation></ref><ref id="pone.0004492-Lodi1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lodi</surname><given-names>R</given-names></name><name><surname>Tonon</surname><given-names>C</given-names></name><name><surname>Valentino</surname><given-names>ML</given-names></name><name><surname>Iotti</surname><given-names>S</given-names></name><name><surname>Clementi</surname><given-names>V</given-names></name><etal/></person-group><year>2004</year><article-title>Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.</article-title><source>Ann Neurol</source><volume>56</volume><fpage>719</fpage><lpage>723</lpage><pub-id pub-id-type="pmid">15505825</pub-id></citation></ref><ref id="pone.0004492-Zanna1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zanna</surname><given-names>C</given-names></name><name><surname>Ghelli</surname><given-names>A</given-names></name><name><surname>Porcelli</surname><given-names>AM</given-names></name><name><surname>Karbowski</surname><given-names>M</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name><etal/></person-group><year>2008</year><article-title>OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.</article-title><source>Brain</source><volume>131</volume><fpage>352</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">18222991</pub-id></citation></ref><ref id="pone.0004492-Olichon2"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olichon</surname><given-names>A</given-names></name><name><surname>Elachouri</surname><given-names>G</given-names></name><name><surname>Baricault</surname><given-names>L</given-names></name><name><surname>Delettre</surname><given-names>C</given-names></name><name><surname>Belenguer</surname><given-names>P</given-names></name><etal/></person-group><year>2007</year><article-title>OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restricted function in apoptosis.</article-title><source>Cell Death Differ</source><volume>14</volume><fpage>682</fpage><lpage>692</lpage><pub-id pub-id-type="pmid">17024226</pub-id></citation></ref><ref id="pone.0004492-Estaquier1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Estaquier</surname><given-names>J</given-names></name><name><surname>Arnoult</surname><given-names>D</given-names></name></person-group><year>2007</year><article-title>Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis.</article-title><source>Cell Death Differ</source><volume>14</volume><fpage>1086</fpage><lpage>1094</lpage><pub-id pub-id-type="pmid">17332775</pub-id></citation></ref><ref id="pone.0004492-Walker1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>DW</given-names></name><name><surname>Hajek</surname><given-names>P</given-names></name><name><surname>Muffat</surname><given-names>J</given-names></name><name><surname>Knoepfle</surname><given-names>D</given-names></name><name><surname>Cornelison</surname><given-names>S</given-names></name><etal/></person-group><year>2006</year><article-title>Hypersensitivity to oxygen and shortened lifespan in a Drosophila mitochondrial complex II mutant.</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>16382</fpage><lpage>16387</lpage><pub-id pub-id-type="pmid">17056719</pub-id></citation></ref><ref id="pone.0004492-Ishii1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>N</given-names></name><name><surname>Fujii</surname><given-names>M</given-names></name><name><surname>Hartman</surname><given-names>PS</given-names></name><name><surname>Tsuda</surname><given-names>M</given-names></name><name><surname>Yasuda</surname><given-names>K</given-names></name><etal/></person-group><year>1998</year><article-title>A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes.</article-title><source>Nature</source><volume>394</volume><fpage>694</fpage><lpage>697</lpage><pub-id pub-id-type="pmid">9716135</pub-id></citation></ref><ref id="pone.0004492-SenooMatsuda1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Senoo-Matsuda</surname><given-names>N</given-names></name><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Tsuda</surname><given-names>M</given-names></name><name><surname>Ohkubo</surname><given-names>T</given-names></name><name><surname>Yoshimura</surname><given-names>S</given-names></name><etal/></person-group><year>2001</year><article-title>A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>41553</fpage><lpage>41558</lpage><pub-id pub-id-type="pmid">11527963</pub-id></citation></ref><ref id="pone.0004492-Hartman1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartman</surname><given-names>P</given-names></name><name><surname>Ponder</surname><given-names>R</given-names></name><name><surname>Lo</surname><given-names>HH</given-names></name><name><surname>Ishii</surname><given-names>N</given-names></name></person-group><year>2004</year><article-title>Mitochondrial oxidative stress can lead to nuclear hypermutability.</article-title><source>Mech Ageing Dev</source><volume>125</volume><fpage>417</fpage><lpage>420</lpage><pub-id pub-id-type="pmid">15178131</pub-id></citation></ref><ref id="pone.0004492-Chen2"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Chomyn</surname><given-names>A</given-names></name><name><surname>Chan</surname><given-names>DC</given-names></name></person-group><year>2005</year><article-title>Disruption of fusion results in mitochondrial heterogeneity and dysfunction.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>26185</fpage><lpage>26192</lpage><pub-id pub-id-type="pmid">15899901</pub-id></citation></ref><ref id="pone.0004492-Spinazzi1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spinazzi</surname><given-names>M</given-names></name><name><surname>Cazzola</surname><given-names>S</given-names></name><name><surname>Bortolozzi</surname><given-names>M</given-names></name><name><surname>Baracca</surname><given-names>A</given-names></name><name><surname>Loro</surname><given-names>E</given-names></name><etal/></person-group><year>2008</year><article-title>A NOVEL DELETION IN THE GTPase DOMAIN OF OPA1 CAUSES DEFECTS IN MITOCHONDRIAL MORPHOLOGY AND DISTRIBUTION, BUT NOT IN FUNCTION.</article-title><source>Hum Mol Genet</source></citation></ref><ref id="pone.0004492-Mayorov1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mayorov</surname><given-names>VI</given-names></name><name><surname>Lowrey</surname><given-names>AJ</given-names></name><name><surname>Biousse</surname><given-names>V</given-names></name><name><surname>Newman</surname><given-names>NN</given-names></name><name><surname>Cline</surname><given-names>SD</given-names></name><etal/></person-group><year>2008</year><article-title>Mitochondrial Oxidative Phosphorylation in Autosomal Dominant Optic Atrophy.</article-title><source>BMC Biochem</source><volume>9</volume><fpage>22</fpage><pub-id pub-id-type="pmid">18783614</pub-id></citation></ref><ref id="pone.0004492-Chan1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>DC</given-names></name></person-group><year>2006</year><article-title>Mitochondria: dynamic organelles in disease, aging, and development.</article-title><source>Cell</source><volume>125</volume><fpage>1241</fpage><lpage>1252</lpage><pub-id pub-id-type="pmid">16814712</pub-id></citation></ref><ref id="pone.0004492-Das1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>N</given-names></name><name><surname>Levine</surname><given-names>RL</given-names></name><name><surname>Orr</surname><given-names>WC</given-names></name><name><surname>Sohal</surname><given-names>RS</given-names></name></person-group><year>2001</year><article-title>Selectivity of protein oxidative damage during aging in Drosophila melanogaster.</article-title><source>Biochem J</source><volume>360</volume><fpage>209</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">11696009</pub-id></citation></ref><ref id="pone.0004492-Yan1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>LJ</given-names></name><name><surname>Levine</surname><given-names>RL</given-names></name><name><surname>Sohal</surname><given-names>RS</given-names></name></person-group><year>1997</year><article-title>Oxidative damage during aging targets mitochondrial aconitase.</article-title><source>Proc Natl Acad Sci U S A</source><volume>94</volume><fpage>11168</fpage><lpage>11172</lpage><pub-id pub-id-type="pmid">9326580</pub-id></citation></ref><ref id="pone.0004492-Tower1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tower</surname><given-names>J</given-names></name></person-group><year>2006</year><article-title>Sex-specific regulation of aging and apoptosis.</article-title><source>Mech Ageing Dev</source><volume>127</volume><fpage>705</fpage><lpage>718</lpage><pub-id pub-id-type="pmid">16764907</pub-id></citation></ref><ref id="pone.0004492-Clancy1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clancy</surname><given-names>DJ</given-names></name><name><surname>Gems</surname><given-names>D</given-names></name><name><surname>Harshman</surname><given-names>LG</given-names></name><name><surname>Oldham</surname><given-names>S</given-names></name><name><surname>Stocker</surname><given-names>H</given-names></name><etal/></person-group><year>2001</year><article-title>Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein.</article-title><source>Science</source><volume>292</volume><fpage>104</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">11292874</pub-id></citation></ref><ref id="pone.0004492-Wang1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>MC</given-names></name><name><surname>Bohmann</surname><given-names>D</given-names></name><name><surname>Jasper</surname><given-names>H</given-names></name></person-group><year>2003</year><article-title>JNK signaling confers tolerance to oxidative stress and extends lifespan in Drosophila.</article-title><source>Dev Cell</source><volume>5</volume><fpage>811</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">14602080</pub-id></citation></ref><ref id="pone.0004492-Spencer1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>CC</given-names></name><name><surname>Howell</surname><given-names>CE</given-names></name><name><surname>Wright</surname><given-names>AR</given-names></name><name><surname>Promislow</surname><given-names>DE</given-names></name></person-group><year>2003</year><article-title>Testing an &#x02018;aging gene&#x02019; in long-lived drosophila strains: increased longevity depends on sex and genetic background.</article-title><source>Aging Cell</source><volume>2</volume><fpage>123</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">12882325</pub-id></citation></ref><ref id="pone.0004492-Kanazawa1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanazawa</surname><given-names>T</given-names></name><name><surname>Zappaterra</surname><given-names>MD</given-names></name><name><surname>Hasegawa</surname><given-names>A</given-names></name><name><surname>Wright</surname><given-names>AP</given-names></name><name><surname>Newman-Smith</surname><given-names>ED</given-names></name><etal/></person-group><year>2008</year><article-title>The C. elegans Opa1 homologue EAT-3 is essential for resistance to free radicals.</article-title><source>PLoS Genet</source><volume>4</volume><fpage>e1000022</fpage><pub-id pub-id-type="pmid">18454199</pub-id></citation></ref><ref id="pone.0004492-1"><label>45</label><citation citation-type="journal"><year>1999</year><article-title>A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics.</article-title><source>Am J Hum Genet</source><volume>65</volume><fpage>1428</fpage><lpage>1436</lpage><pub-id pub-id-type="pmid">10521310</pub-id></citation></ref><ref id="pone.0004492-Tong1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>JJ</given-names></name><name><surname>Schriner</surname><given-names>SE</given-names></name><name><surname>McCleary</surname><given-names>D</given-names></name><name><surname>Day</surname><given-names>BJ</given-names></name><name><surname>Wallace</surname><given-names>DC</given-names></name></person-group><year>2007</year><article-title>Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster.</article-title><source>Nat Genet</source><volume>39</volume><fpage>476</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">17369827</pub-id></citation></ref><ref id="pone.0004492-Barrientos1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrientos</surname><given-names>A</given-names></name></person-group><year>2002</year><article-title>In vivo and in organello assessment of OXPHOS activities.</article-title><source>Methods</source><volume>26</volume><fpage>307</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">12054921</pub-id></citation></ref><ref id="pone.0004492-Hausladen1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hausladen</surname><given-names>A</given-names></name><name><surname>Fridovich</surname><given-names>I</given-names></name></person-group><year>1996</year><article-title>Measuring nitric oxide and superoxide: rate constants for aconitase reactivity.</article-title><source>Methods Enzymol</source><volume>269</volume><fpage>37</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">8791635</pub-id></citation></ref><ref id="pone.0004492-Trounce1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trounce</surname><given-names>IA</given-names></name><name><surname>Kim</surname><given-names>YL</given-names></name><name><surname>Jun</surname><given-names>AS</given-names></name><name><surname>Wallace</surname><given-names>DC</given-names></name></person-group><year>1996</year><article-title>Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines.</article-title><source>Methods Enzymol</source><volume>264</volume><fpage>484</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">8965721</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This project was partially supported by the Helen &#x00026; Larry Hoag Foundation, an NIH Clinical Associate Physician Award, the Howard Hughes Biomedical Science Program, a UCI Junior Physician-Scientists Award and NEI 1R01EY018876 to TH. ST is supported by the Cystinosis Research Foundation. DCW is supported by the following NIH research grant NS21328, AG24373, DK73691, AG13154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 